We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
CYSTADROPS (Recordati Rare Diseases Australia Pty Ltd)
Product name
CYSTADROPS
Date registered
Evaluation commenced
Decision date
Approval time
218 (255 working days)
Active ingredients
mercaptamine (cysteamine)
Registration type
EOI
Indication
CYSTADROPS (eye drop solution) is indicated for the treatment of corneal cystine deposits in adults and children with cystinosis.
Registration process
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.